Article Text
Abstract
Slowly progressive neuromuscular symptoms often have a genetic basis. We present the case of a woman in her 40s with gradually progressive symmetrical weakness and respiratory muscle involvement. Extensive investigation found no specific cause. After a novel neuromuscular gene panel became available, we identified a mutation in the MUSK gene (muscle-specific kinase), confirming a diagnosis of congenital myasthenic syndrome. This group of rare disorders are caused by mutations in genes encoding the neuromuscular junction.
- MYASTHENIA
- NEUROMUSCULAR
- NEUROGENETICS
Data availability statement
Data sharing not applicable as no datasets generated and/or analysed for this study.
Statistics from Altmetric.com
Data availability statement
Data sharing not applicable as no datasets generated and/or analysed for this study.
Footnotes
Contributors The patient in the case was identified and managed by IW. The literature review was conducted by AM, and the case report was written by AM with input from IW.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned. Externally peer reviewed by Jacqueline Palace, Oxford, UK.
Linked Articles
- Editorial
Read the full text or download the PDF:
Other content recommended for you
- Neuromuscular junction disorders: mimics and chameleons
- Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
- Myasthenia and related disorders of the neuromuscular junction
- A ‘limb-girdle muscular dystrophy’ responsive to asthma therapy
- Congenital familial myasthenic syndromes: disease and course in an affected dizygotic twin pair
- Clinical features of the myasthenic syndrome arising from mutations in GMPPB
- Congenital myasthenic syndromes: an update
- Congenital myasthenic syndromes
- Homozygous C-terminal loss-of-function NaV1.4 variant in a patient with congenital myasthenic syndrome
- Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity